Elicera Therapeutics AB's market cap is currently kr241.22M. The company's EPS TTM is kr-0.056; its P/E ratio is ―; Elicera Therapeutics AB is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in SEK
Elicera Therapeutics AB Earnings and Revenue History
